Search Page

1

Cite

Share

Nintedanib with Add-on Pirfenidone in Idiopathic Pulmonary Fibrosis. Results of the INJOURNEY Trial.

Vancheri C, Kreuter M, Richeldi L, Ryerson CJ, Valeyre D, Grutters JC, Wiebe S, Stansen W, Quaresma M, Stowasser S, Wuyts WA; INJOURNEY Trial Investigators. Vancheri C, et al. Among authors: stansen w. Am J Respir Crit Care Med. 2018 Feb 1;197(3):356-363. doi: 10.1164/rccm.201706-1301OC. Am J Respir Crit Care Med. 2018. PMID: 28889759 Clinical Trial.

Cite

Share

2

Cite

Share

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities.

Glaspole I, Bonella F, Bargagli E, Glassberg MK, Caro F, Stansen W, Quaresma M, Orsatti L, Bendstrup E. Glaspole I, et al. Among authors: stansen w. Respir Res. 2021 Apr 26;22(1):125. doi: 10.1186/s12931-021-01695-y. Respir Res. 2021. PMID: 33902584 Free PMC article.

Cite

Share

3

Cite

Share

Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.

Crestani B, Huggins JT, Kaye M, Costabel U, Glaspole I, Ogura T, Song JW, Stansen W, Quaresma M, Stowasser S, Kreuter M. Crestani B, et al. Among authors: stansen w. Lancet Respir Med. 2019 Jan;7(1):60-68. doi: 10.1016/S2213-2600(18)30339-4. Epub 2018 Sep 14. Lancet Respir Med. 2019. PMID: 30224318 Clinical Trial.

Cite

Share

4

Cite

Share

Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.

Cottin V, Azuma A, Raghu G, Stansen W, Stowasser S, Schlenker-Herceg R, Kolb M. Cottin V, et al. Among authors: stansen w. Eur Respir J. 2019 Apr 18;53(4):1801655. doi: 10.1183/13993003.01655-2018. Print 2019 Apr. Eur Respir J. 2019. PMID: 30655282 Free article. Clinical Trial. No abstract available.

Cite

Share

5

Cite

Share

Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis.

Jouneau S, Crestani B, Thibault R, Lederlin M, Vernhet L, Valenzuela C, Wijsenbeek M, Kreuter M, Stansen W, Quaresma M, Cottin V. Jouneau S, et al. Among authors: stansen w. Respir Res. 2020 Nov 25;21(1):312. doi: 10.1186/s12931-020-01528-4. Respir Res. 2020. PMID: 33239000 Free PMC article. Clinical Trial.

Cite

Share

6

Cite

Share

Long-term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®-ON.

Song JW, Ogura T, Inoue Y, Xu Z, Quaresma M, Stowasser S, Stansen W, Crestani B. Song JW, et al. Among authors: stansen w. Respirology. 2020 Apr;25(4):410-416. doi: 10.1111/resp.13647. Epub 2019 Jul 22. Respirology. 2020. PMID: 31329360 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Reply: Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.

Costabel U, Stansen W, Stowasser S. Costabel U, et al. Among authors: stansen w. Am J Respir Crit Care Med. 2017 May 1;195(9):1275. doi: 10.1164/rccm.201610-2155LE. Am J Respir Crit Care Med. 2017. PMID: 28459331 No abstract available.

Cite

Share

8

Cite

Share

Anti-acid therapy in idiopathic pulmonary fibrosis: insights from the INPULSIS® trials.

Costabel U, Behr J, Crestani B, Stansen W, Schlenker-Herceg R, Stowasser S, Raghu G. Costabel U, et al. Among authors: stansen w. Respir Res. 2018 Sep 3;19(1):167. doi: 10.1186/s12931-018-0866-0. Respir Res. 2018. PMID: 30176872 Free PMC article. Clinical Trial.

Cite

Share

9

Cite

Share

Lung function outcomes in the INPULSIS^® trials of nintedanib in idiopathic pulmonary fibrosis.

Brown KK, Flaherty KR, Cottin V, Raghu G, Inoue Y, Azuma A, Huggins JT, Richeldi L, Stowasser S, Stansen W, Schlenker-Herceg R, Maher TM, Wells AU. Brown KK, et al. Among authors: stansen w. Respir Med. 2019 Jan;146:42-48. doi: 10.1016/j.rmed.2018.11.012. Epub 2018 Nov 19. Respir Med. 2019. PMID: 30665517 Free article. Clinical Trial.

Cite

Share

10

Cite

Share

Health-related quality of life and symptoms in patients with IPF treated with nintedanib: analyses of patient-reported outcomes from the INPULSIS® trials.

Kreuter M, Wuyts WA, Wijsenbeek M, Bajwah S, Maher TM, Stowasser S, Male N, Stansen W, Schoof N, Orsatti L, Swigris J. Kreuter M, et al. Among authors: stansen w. Respir Res. 2020 Jan 30;21(1):36. doi: 10.1186/s12931-020-1298-1. Respir Res. 2020. PMID: 32000772 Free PMC article. Clinical Trial.

Cite

Share